GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation

Journal of Neurochemistry

Volumn 74, Issue 3, 2000, Pages 1166-1174

  Betarbet, Ranjita ^a   Porter, Richard H P ^b   Greenamyre, J Timothy ^a,c  

^a EMORY UNIVERSITY   (United States)

^b Cerebrus Limited   (United Kingdom)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Basal ganglia; GluR1 receptor; Immunoautoradiography; Nigrostriatal denervation; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DENERVATION; FEMALE; GLOBUS PALLIDUS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALIA; PRIMATES;

EID: 0033977075     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.741166.x     Document Type: Article

References (48)

1. Albin R. L., Young A. B., and Penny J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
2. Albin R. L., Makowiec R. L., Hollingsworth Z., Dure L. S. IV, Penney J. B., and Young A. B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46, 35-48.
3. Anglade P., Mouatt-Prigent A., Agid Y., and Hirsch E. C. (1996) Synaptic plasticity in the caudate nucleus of patients with Parkin-son's disease. Neurodegeneration 5, 121-128.
4. Bergman H., Wichmann T., Karmon B., and DeLong M. R. (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 72, 507-520.
5. Bernard V., Gardiol A., Faucheux B., Bloch B., Agid Y., and Hirsch E. C. (1996) Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. J. Comp. Neurol. 368, 553-568.
6. Bernard V., Somogyi P., and Bolam J. P. (1997) Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J. Neurosci. 17, 819-833.
7. Blackstone C. D., Moss S. J., Martin L. J., Levey A. I., Price D. L., and Huganir R. L. (1992) Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J. Neurochem. 58, 1118-1126.
8. Blandini F., Greenamyre J. T., and Nappi G. (1996) The role of glutamate in the pathophysiology of Parkinson's disease. Funct. Neurol. 11, 3-15.
9. Blandini F., Garcia-Osuna M., and Greenamyre J. T. (1997) Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats. Eur. J. Neurosci. 9, 1407-1413.
10. Boulter J., Bettler B., Dingledine R., Edgebjerg J., Hartley M., Hermans-Borgmeyer I., Hollmann M., Hume R. I., Rogers S., and Heinemann S. (1992) Molecular biology of the glutamate receptors. Clin. Neuropharmacol. 15, 60A-61A.
11. Burbaud P., Gross C., Benazzouz A., Coussemacq M., and Bioulac B. (1995) Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of a firing rate and discharge pattern of pars reticulata neurons. Exp. Brain Res. 105, 48-58.
12. Calabresi P., Mercuri N. B., Sancesario G., and Bernardi G. (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain 116, 433-452.
13. Chen Q., Veenman C. L., and Reiner A. (1996) Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73, 715-731.
14. Ciliax B., Greenamyre J. T., and Levey A. I. (1996) Functional biochemistry and molecular neuropharmacology of the basal ganglia and motor systems, in Movement Disorders. Neurologic Principles and Practice (Watts R. L. and Koller W. C., eds), pp. 99-116. McGraw-Hill, New York.
15. Crossman A. R. (1989) Neural mechanisms in disorders of movement. Comp. Biochem. Physiol. 93, 141-149.
16. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
17. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15, 133-139.
18. Greenamyre J. T. (1993) Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J. Neural Transm. 91, 255-269.
19. Greenamyre J. T. and O'Brien C. F. (1991) N-Methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol. 48, 977-981.
20. He Y., Lee T., and Leong S. K. (1998) Effect of 6-OHDA injection on the AMPA glutamate receptor subunits in the substantia nigra of Sprague-Dawley rats. Neurosci. Lett. 241, 1-4.
21. Hollmann M. and Heineman S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
22. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on the subunit composition. Science 252, 851-853.
23. Hornykiewicz O. and Kish S. J. (1987) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
24. Ingham C. A., Hood S. H., Taggart P., and Arbuthnott G. W. (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci. 15, 4732-4743.
25. Kita H. and Kitai S. T. (1987) Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J. Comp. Neurol. 260, 435-452.
26. Klockgether T. and Turski L. (1989) Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci. 12, 285-286.
27. Klockgether T. and Turski L. (1993) Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann. Neurol. 34, 585-593.
28. Klockgether T., Turski L., Honore T., Zhang Z. M., Gash D. M., Kurlan R., and Greenamyre J. T. (1991) The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoaminedepleted rats and MPTP-treated monkeys. Ann. Neurol. 30, 717-723.
29. Lindefors N. and Ungerstedt U. (1990) Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci. Lett. 115, 248-252.
30. Loschmann P. A., Kunow M., and Wachtel H. (1992) Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease. J. Neural Transm. Suppl. 38, 55-64.
31. Marshall J. F., Critchfield J. W., and Kozlowski M. R. (1981) Altered succinate dehydrogenase activity of basal ganglia following damage to mesotelencephalic dopaminergic projection. Brain Res. 212, 367-377.
32. Martin L. J., Blackstone C. D., Huganir R. L., and Price D. L. (1993a) The striatal mosaic in primates: striosomes and matrix are differentially enriched in ionotropic glutamate receptor subunits. J. Neurosci. 13, 782-792.
33. Martin L. J., Blackstone C. D., Levey A. I., Huganir R. L., and Price D. L. (1993b) AMPA glutamate subunits are differentially distributed in rat brain. Neuroscience 53, 327-358.
34. Miller W. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, in The Basal Ganglia II (Carpenter M. B. and Jayaraman A., eds), pp. 414-427. Plenum, New York.
35. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D. E., Sambrook M. A., and Crossman A. R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32, 213-226.
36. Nakanishi S. and Masu M. (1994) Molecular diversity and functions of glutamate receptors. Annu. Rev. Biophys. Biomol. Struct. 23, 319-348.
37. Paquet M., Tremblay M., Soghomonian J.-J., and Smith Y. (1997) AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochem-ical and in situ hybridization study. J. Neurosci. 17, 1377-1396.
38. Petralia R. S. and Wenthold R. J. (1992) Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J. Comp. Neurol. 318, 329-354.
39. Porter R. H. P., Greene J. G., Higgins D. S. Jr., and Greenamyre J. T. (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 14, 7192-7199.
40. Price R. H. Jr., Hollingsworth Z., Young A. B., and Penney J. B. Jr. (1993) Excitatory amino acid receptor regulation after subthalamic nucleus lesions in rats. Brain Res. 602, 157-160.
41. Rouzaire-Dubois B. and Scarnati E. (1987) Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: evidence for amino acids as putative neurotransmitters. Neuroscience 21, 429-440.
42. Standaert D. G., Testa C. M., Young A. B., and Penney J. B. Jr. (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of rat. J. Comp. Neurol. 343, 1-16.
43. Starr M. S. (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19, 264-293.
44. Testa C. M., Standaert D. G., Young A. B., and Penney J. B. (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14, 3005-3018.
45. Tremblay M., Salin P., and Soghomonian J.-J. (1995) Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits. Neuroreport 6, 2225-2229.
46. Wichmann T., Bergman H., and DeLong M. R. (1994) The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J. Neurophysiol. 72, 521-530.
47. Wullner U., Brouillet E., Isacson O., Young A. B., and Penney J. B. (1993) Glutamate receptor binding sites in MPTP-treated mice. Exp. Neurol. 121, 284-287.
48. Wullner U., Testa C. M., Catania M. V., Young A. B., and Penney J. B. (1994) Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res. 645, 98-102.